JIANG ZHONG PHARMACEUTICAL CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.98 CNY | -0.22% |
|
-1.60% | +29.21% |
| Mar. 25 | Jiang Zhong Pharmaceutical Co.,Ltd Proposes Cash Dividend | CI |
| Mar. 22 | Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2024 * | 4.98B 688M | Sales 2025 * | 5.69B 785M | Capitalization | 16.81B 2.32B |
|---|---|---|---|---|---|
| Net income 2024 * | 825M 114M | Net income 2025 * | 937M 129M | EV / Sales 2024 * | 3.11 x |
| Net cash position 2024 * | 1.29B 178M | Net cash position 2025 * | 1.13B 157M | EV / Sales 2025 * | 2.76 x |
| P/E ratio 2024 * |
20.6
x | P/E ratio 2025 * |
18.1
x | Employees | - |
| Yield 2024 * |
5.04% | Yield 2025 * |
5.36% | Free-Float | 51.07% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.22% | ||
| 1 week | -1.60% | ||
| Current month | +9.23% | ||
| 1 month | +19.75% | ||
| 3 months | +35.65% | ||
| 6 months | +49.23% | ||
| Current year | +29.21% |
1 week
26.58
28.58
1 month
22.7928.58
Current year
19.1128.58
1 year
17.5028.58
3 years
10.5428.58
5 years
9.3328.58
10 years
7.2728.58
| Managers | Title | Age | Since |
|---|---|---|---|
Wen Bin Xiao
CEO | Chief Executive Officer | 44 | 21-01-11 |
Xiao Jun Li
DFI | Director of Finance/CFO | 43 | 20-03-18 |
Yang Tang
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wei Quan Liu
CHM | Chairman | 53 | 09-09-17 |
Na Tang
BRD | Director/Board Member | 48 | 22-11-16 |
Rong Deng
BRD | Director/Board Member | 46 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.25% | 4 M€ | -2.96% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 26.98 | -0.22% | 7 628 366 |
| 24-04-23 | 27.04 | -1.31% | 12,662,210 |
| 24-04-22 | 27.4 | -1.97% | 12,946,420 |
| 24-04-19 | 27.95 | +1.19% | 7,863,097 |
| 24-04-18 | 27.62 | +0.88% | 9,362,719 |
End-of-day quote Shanghai S.E., April 23, 2024
More quotes
JIANGZHONG PHARMACEUTICAL CO., LTD is a China-based company principally engaged in the manufacture, research and development and sales of over-the-counter (OTC) pharmaceuticals and healthcare products. The Companyâs products include OTC medicines, healthcare products and functional food, as well as wine. Its OTC pharmaceuticals include indigestion tablets, lactobacillin tablets and sarcandra glabra tablets, among others. Its healthcare products and functional food include calcium tablets and ginseng products, among others. The Company mainly operates its businesses in domestic market.
Sector
Pharmaceuticals
Calendar
2024-04-26
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
26.98
CNY
Average target price
30.62
CNY
Spread / Average Target
+13.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +29.21% | 2.33B | |
| +25.61% | 672B | |
| +25.87% | 570B | |
| -5.24% | 360B | |
| +16.49% | 321B | |
| +8.28% | 300B | |
| +7.09% | 217B | |
| -9.12% | 204B | |
| +5.01% | 199B | |
| -8.75% | 149B |
- Stock Market
- Equities
- 600750 Stock
